When did CORCEPT THERAPEUTICS INC (CORT) report earnings last quarter?
CORCEPT THERAPEUTICS INC (CORT) last reported earnings on 2/24/2026.
CORCEPT THERAPEUTICS INC (CORT) Earnings History & Surprises
NASDAQ:CORT • US2183521028
Current stock price
46.06 USD
+0.98 (+2.17%)
At close:
45.9215 USD
-0.14 (-0.3%)
After Hours:
CORT Earnings overview
Past quarterly earnings results for CORCEPT THERAPEUTICS INC (CORT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 30, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.02
- Revenue Estimate
- 196.36M
Last Reported
Most Recent- Release Date
- Feb 24, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.20
- EPS Surprise
- -34.64%
- Revenue Surprise
- -22.27%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.20 | 0.31 | -34.64% | -23.08% | 202.125M | 260.03M | -22.27% | 11.12% |
| Q3 2025 | 0.16 | 0.14 | 16.19% | -60.98% | 207.638M | 222.9M | -6.85% | 13.75% |
| Q2 2025 | 0.29 | 0.19 | 51.63% | -9.38% | 194.43M | 203.38M | -4.40% | 18.70% |
| Q1 2025 | 0.17 | 0.15 | 16.96% | -32.00% | 157.214M | 181.49M | -13.38% | 7.09% |
| Q4 2024 | 0.26 | 0.43 | -40.20% | -7.14% | 181.89M | 202.66M | -10.25% | 34.33% |
| Q3 2024 | 0.41 | 0.29 | 42.54% | 46.43% | 182.546M | 175.41M | 4.07% | 47.69% |
| Q2 2024 | 0.32 | 0.23 | 36.40% | 28.00% | 163.796M | 158.33M | 3.45% | 39.15% |
| Q1 2024 | 0.25 | 0.22 | 11.41% | 78.57% | 146.808M | 144.03M | 1.93% | 38.95% |
| Q4 2023 | 0.28 | 0.26 | 6.40% | 100.00% | 135.405M | 131.89M | 2.67% | 31.33% |
| Q3 2023 | 0.28 | 0.22 | 25.73% | -6.67% | 123.601M | 122.07M | 1.25% | 21.53% |
| Q2 2023 | 0.25 | 0.15 | 63.40% | 4.17% | 117.715M | 111.88M | 5.22% | 13.84% |
| Q1 2023 | 0.14 | 0.20 | -29.00% | -30.00% | 105.654M | 106.97M | -1.23% | 12.76% |
| Q4 2022 | 0.14 | 0.23 | -39.00% | -46.15% | 103.1M | 107.18M | -3.81% | 4.35% |
| Q3 2022 | 0.30 | 0.23 | 30.72% | 25.00% | 101.7M | 109.74M | -7.33% | 5.83% |
| Q2 2022 | 0.24 | 0.24 | 0.13% | 14.29% | 103.4M | 103.02M | 0.37% | 12.88% |
| Q1 2022 | 0.20 | 0.24 | -17.61% | 11.11% | 93.7M | 100.86M | -7.10% | 18.01% |
| Q4 2021 | 0.26 | 0.22 | 18.56% | 30.00% | 98.8M | 102.58M | -3.68% | 15.29% |
| Q3 2021 | 0.24 | 0.20 | 19.14% | 41.18% | 96.1M | 99.133M | -3.06% | 11.36% |
| Q2 2021 | 0.21 | 0.16 | 30.72% | -8.70% | 91.6M | 88.578M | 3.41% | 3.39% |
| Q1 2021 | 0.18 | 0.21 | -15.97% | -28.00% | 79.4M | 93.643M | -15.21% | -14.81% |
| Q4 2020 | 0.20 | 0.19 | 5.04% | - | 85.7M | 89.529M | -4.28% | - |
| Q3 2020 | 0.17 | 0.21 | -18.70% | - | 86.3M | 92.69M | -6.89% | - |
| Q2 2020 | 0.23 | 0.23 | 1.34% | - | 88.6M | 91.94M | -3.63% | - |
| Q1 2020 | 0.25 | 0.22 | 11.41% | - | 93.2M | 88.746M | 5.02% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
12.54%
Max EPS beat (4)
51.63%
Min EPS beat (4)
-34.64%
Revenue beat statistics
Revenue beat (4)
0
Average Revenue beat (4)
-11.72%
Max Revenue beat (4)
-4.40%
Min Revenue beat (4)
-22.27%
Analysis
In the last 4 quarters, CORT has beaten EPS estimates in 3 out of 4 releases
CORT has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, CORT has beaten the EPS estimates by 12.5% on average.
In the last 4 quarters, CORT reported -11.7% below the revenue estimates on average.
Related analysis
CORCEPT THERAPEUTICS INC / CORT Earnings FAQ
Did CORCEPT THERAPEUTICS INC (CORT) beat earnings estimates last quarter?
CORCEPT THERAPEUTICS INC (CORT) missed EPS estimates and missed revenue estimates in the most recent quarter.
What percentage of the time does CORT stock beat earnings estimates?
In the last 4 quarters, CORCEPT THERAPEUTICS INC (CORT) has beaten EPS estimates in 3 out of 4 releases.